TY - JOUR
T1 - Methicillin resistance in Staphylococcus aureus requires glycosylated wall teichoic acids
AU - Brown, Stephanie
AU - Xia, Guoqing
AU - Luhachack, Lyly G.
AU - Campbell, Jennifer
AU - Meredith, Timothy C.
AU - Chen, Calvin
AU - Winstel, Volker
AU - Gekeler, Cordula
AU - Irazoqui, Javier E.
AU - Peschel, Andreas
AU - Walker, Suzanne
PY - 2012/11/13
Y1 - 2012/11/13
N2 - Staphylococcus aureus peptidoglycan (PG) is densely functionalized with anionic polymers called wall teichoic acids (WTAs). These polymers contain three tailoring modifications: D-alanylation, α-O-GlcNAcylation, and β-O-GlcNAcylation. Here we describe the discovery and biochemical characterization of a unique glycosyltransferase, TarS, that attaches β-O-GlcNAc (β-O-N-acetyl-D-glucosamine) residues to S. aureus WTAs. We report that methicillin resistant S. aureus (MRSA) is sensitized to β-lactams upon tarS deletion. Unlike strains completely lacking WTAs, which are also sensitive to β-lactams, ΔtarS strains have no growth or cell division defects. Because neither α-O-GlcNAc nor β-O-Glucose modifications can confer resistance, the resistance phenotype requires a highly specific chemical modification of the WTA backbone, β-O-GlcNAc residues. These data suggest β-O-GlcNAcylated WTAs scaffold factors required for MRSA resistance. The β-O-GlcNAc transferase identified here, TarS, is a unique target for antimicrobials that sensitize MRSA to β-lactams.
AB - Staphylococcus aureus peptidoglycan (PG) is densely functionalized with anionic polymers called wall teichoic acids (WTAs). These polymers contain three tailoring modifications: D-alanylation, α-O-GlcNAcylation, and β-O-GlcNAcylation. Here we describe the discovery and biochemical characterization of a unique glycosyltransferase, TarS, that attaches β-O-GlcNAc (β-O-N-acetyl-D-glucosamine) residues to S. aureus WTAs. We report that methicillin resistant S. aureus (MRSA) is sensitized to β-lactams upon tarS deletion. Unlike strains completely lacking WTAs, which are also sensitive to β-lactams, ΔtarS strains have no growth or cell division defects. Because neither α-O-GlcNAc nor β-O-Glucose modifications can confer resistance, the resistance phenotype requires a highly specific chemical modification of the WTA backbone, β-O-GlcNAc residues. These data suggest β-O-GlcNAcylated WTAs scaffold factors required for MRSA resistance. The β-O-GlcNAc transferase identified here, TarS, is a unique target for antimicrobials that sensitize MRSA to β-lactams.
UR - http://www.scopus.com/inward/record.url?scp=84869214183&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84869214183&partnerID=8YFLogxK
U2 - 10.1073/pnas.1209126109
DO - 10.1073/pnas.1209126109
M3 - Article
C2 - 23027967
AN - SCOPUS:84869214183
SN - 0027-8424
VL - 109
SP - 18909
EP - 18914
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
IS - 46
ER -